Navellier & Associates’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-29,068
| Closed | -$763K | – | 350 |
|
|
2021
Q1 | $763K | Buy |
29,068
+2,747
| +10% | +$72.1K | 0.14% | 138 |
|
|
2020
Q4 | $492K | Buy |
26,321
+3,030
| +13% | +$56.6K | 0.09% | 169 |
|
|
2020
Q3 | $395K | Buy |
23,291
+3,453
| +17% | +$58.6K | 0.09% | 163 |
|
|
2020
Q2 | $462K | Buy |
+19,838
| New | +$462K | 0.11% | 139 |
|
|
2017
Q1 | – | Sell |
-50,463
| Closed | -$893K | – | 321 |
|
|
2016
Q4 | $893K | Buy |
50,463
+8,229
| +19% | +$146K | 0.15% | 138 |
|
|
2016
Q3 | $815K | Buy |
42,234
+10,601
| +34% | +$205K | 0.12% | 141 |
|
|
2016
Q2 | $617K | Buy |
31,633
+13,534
| +75% | +$264K | 0.09% | 125 |
|
|
2016
Q1 | $373K | Buy |
+18,099
| New | +$373K | 0.05% | 146 |
|